Oliceridine for ICU sedation and pain
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests a new pain and sedation medicine called Oliceridine for patients in the ICU who are on a breathing machine. It aims to see if it works safely and effectively to help you stay comfortable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- You are in the ICU and on a breathing machine (ventilator) that will be needed for more than 24 hours.
- You need medication to keep you calm or to manage pain.
- You are not allergic to opioid pain relievers (like morphine, fentanyl).
- You do not have chronic pain that requires daily pain medication for more than 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a pain medicine called oxycodone for patients on breathing machines in the ICU. It aims to see if it provides safe and effective long-term pain control.
This study tests a pain medicine called hydromorphone for people in the ICU who need a breathing tube. The goal is to see how well it works and if it's safe for managing pain and sedation.
This trial tests a new sedation protocol for adults in intensive care who need strong pain relief or sedation medicines. It aims to make sedation safer and more comfortable, and includes people on ECMO (a heart-lung machine) or a ventilator (breathing machine) for severe breathing problems.
This trial tests a new pain medicine called oliceridine for patients recovering from open or laparoscopic abdominal surgery. It aims to see if it works well and is safe for controlling acute pain after the procedure.
This study tests a new pain medicine called oliceridine after laparoscopic upper abdominal surgery. It aims to improve pain control and recovery compared to standard opioids.
This study tests whether a new pain medication (oliceridine) given through an IV patient-controlled pump can reduce chronic pain after lung surgery. Participants will receive either oliceridine or a standard opioid for pain control after a minimally invasive lung resection. The study will follow patients for several months to see if they develop long-term pain.
Hear when a new Analgesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.